Type 2 Diabetes, Obesity research hub

A three-part first-in-human trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of GUB-UCN2 in healthy lean and obese participants and participants with T2D

This early-stage study is testing a new medicine called GUB-UCN2. It's looking at how safe it is and what it does in the body. We're testing it in healthy people, those with obesity, and people with type 2 diabetes. We want to see how the body handles the medicine.